nicotinoylprocaine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 159667 |
| SCHEMBL ID | 3079077 |
| MeSH ID | M0074882 |
| Synonym |
|---|
| 13424-56-1 |
| nicotinoylprocaine |
| 2-diethylaminoethyl 4-(pyridine-3-carbonylamino)benzoate |
| unii-2u2oxg6o70 |
| 2u2oxg6o70 , |
| nicotinoyl procaine |
| SCHEMBL3079077 |
| nicotinoylprocaine [who-dd] |
| n-nicotinoylprocaine |
| benzoic acid, 4-((3-pyridinylcarbonyl)amino)-, 2-(diethylamino)ethyl ester |
| atheroplex |
| d-348 |
| benzoic acid, p-nicotinamido-, 2-(diethylamino)ethyl ester |
| DTXSID50158606 |
| Q27255595 |
| 2-(diethylamino)ethyl 4-(pyridine-3-carbonylamino)benzoate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||